This 225-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 225 pages and 6 tables  Research Beam Model: Research Beam Product ID: 335912 0 USD New
2016 Emerging Blood Typing, Grouping and NAT Screening Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

2016 Emerging Blood Typing, Grouping and NAT Screening Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers

 
  • Category : Diagnostic and Biotech
  • Published On : October  2015
  • Pages : 225
 
 

This 225-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.

The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. 

Contains 225 pages and 6 tables